Institutional Ownership
Diamedica Therapeutics Inc
CUSIP 25253X207COM NEWDMACQ1 2026
13D / 13G Filings
27
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
16.9%
Max % of class reported
Institutional Holders
93
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
27 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Cooperman Leon G. | 13G/A | 6.6% | 3.45M | SEC |
| 2 | Feb 17, 2026 | Dialectic Life Sciences Spv LLC | 13G/A | 0.3% | 154.0K | SEC |
| 3 | Feb 6, 2026 | Trill Ab | 13G/A | 16.9% | 8.83M | SEC |
| 4 | Nov 7, 2025 | Richard Jacinto II | 13G/A | 9.6% | 4.96M | SEC |
| 5 | Oct 15, 2025 | Cooperman Leon G. | 13G/A | 6.3% | 3.27M | SEC |
| 6 | Sep 4, 2025 | Trill Ab | 13G/A | 15.0% | 7.76M | SEC |
| 7 | Aug 27, 2025 | Cooperman Leon G. | 13G | 6.0% | 3.11M | SEC |
| 8 | Jul 30, 2025 | Trill Ab | 13G/A | 13.1% | 6.76M | SEC |
| 9 | Jul 30, 2025 | Tomenterprise Ab | 13G/A | 16.3% | 8.38M | SEC |
| 10 | Jul 8, 2024 | Dialectic Capital Management, LP | 13G | 5.1% | 2.17M | SEC |
17 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Diamedica Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Cooperman Leon G | 2.02M | $13.68M |
| 2 | Blackrock, Inc. | 1.86M | $12.57M |
| 3 | Millennium Management LLC | 935.6K | $6.33M |
| 4 | Paragon Associates & Paragon Associates II Joint Venture | 875.0K | $5.92M |
| 5 | Geode Capital Management, LLC | 780.5K | $5.29M |
| 6 | State Street Corp | 644.2K | $4.36M |
| 7 | First Manhattan Co. LLC. | 455.0K | $3.08M |
| 8 | Bleichroeder LP | 382.3K | $2.59M |
| 9 | Northern Trust Corp | 338.5K | $2.29M |
| 10 | Osaic Holdings, Inc. | 319.7K | $2.16M |